nach oben

International Journal of Hematology

Erschienen in:

01.04.2014 | Case Report

Primary bone marrow Hodgkin lymphoma in an HIV-negative patient

verfasst von: Bhagirathbhai Dholaria, Daisy Alapat, Konstantinos Arnaoutakis

Erschienen in: International Journal of Hematology | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

Classical Hodgkin lymphoma has distinct clinicopathological features and shows good response to treatment in most cases. Primary bone marrow-limited Hodgkin lymphoma is uncommon and primarily described in HIV-positive patients. It behaves as a distinct entity with aggressive clinical course and poor response to available treatments. We discuss here a case of Hodgkin lymphoma with isolated involvement of bone marrow in an HIV-negative patient, which was successfully treated with conventional chemotherapy.

National Cancer Institute (NCI) Surveillance Epidemiology and End Results (SEER). National Cancer Institute. 2013. http://seer.cancer.gov. Accessed June 18 2013.

Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood. 2011;117(19):5019–32.PubMedCentralPubMedCrossRef

Clarke CA, Glaser SL, Prehn AW. Age-specific survival after Hodgkin’s disease in a population-based cohort (United States). Cancer Causes Control CCC. 2001;12(9):803–12.PubMedCrossRef

Moid F, DePalma L. Comparison of relative value of bone marrow aspirates and bone marrow trephine biopsies in the diagnosis of solid tumor metastasis and Hodgkin lymphoma : institutional experience and literature review. Arch Pathol Lab Med. 2005;129(4):497–501. doi:10.1043/1543-2165(2005)129<497:corvob>2.0.co;2.PubMed

Howell SJ, Grey M, Chang J, Morgenstern GR, Cowan RA, Deakin DP, et al. The value of bone marrow examination in the staging of Hodgkin’s lymphoma: a review of 955 cases seen in a regional cancer centre. Br J Haematol. 2002;119(2):408–11.PubMedCrossRef

Carbone A, Gloghini A, Serraino D, Spina M. HIV-associated Hodgkin lymphoma. Current Opinion HIV AIDS. 2009;4(1):3–10. doi:10.1097/COH.0b013e32831a722b.CrossRef

Tirelli U, Errante D, Dolcetti R, Gloghini A, Serraino D, Vaccher E, et al. Hodgkin’s disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors. J Clin Oncol Off J Am Soc Clin Oncol. 1995;13(7):1758–67.

Andrieu JM, Roithmann S, Tourani JM, Levy R, Desablens B, le Maignan C, et al. Hodgkin’s disease during HIV1 infection: the French registry experience. French Registry of HIV-associated Tumors. Ann Oncol. 1993;4(8):635–41.PubMed

Herida M, Mary-Krause M, Kaphan R, Cadranel J, Poizot-Martin I, Rabaud C, et al. Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients. J Clin Oncol Off J Am Soc Clin Oncol. 2003;21(18):3447–53. doi:10.1200/jco.2003.01.096.CrossRef

10.

Ponzoni M, Fumagalli L, Rossi G, Freschi M, Re A, Vigano MG, et al. Isolated bone marrow manifestation of HIV-associated Hodgkin lymphoma. Modern Pathol Off J US Can Acad Pathol Inc. 2002;15(12):1273–8. doi:10.1097/01.mp.0000037311.56159.13.

11.

Shah BK, Subramaniam S, Peace D, Garcia C. HIV-associated primary bone marrow Hodgkin’s lymphoma: a distinct entity? J Clin Oncol Off J Am Soc Clin Oncol. 2010;28(27):e459–60. doi:10.1200/jco.2010.28.3077.CrossRef

12.

Ponzoni M, Ciceri F, Crocchiolo R, Famoso G, Doglioni C. Isolated bone marrow occurrence of classic Hodgkin’s lymphoma in an HIV-negative patient. Haematologica. 2006;91(3):ECR04-ECR.

13.

Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Aoun P, Bello CM, et al. Hodgkin lymphoma, version 2.2012 featured updates to the NCCN guidelines. J Natl Compr Cancer Network JNCCN. 2012;10(5):589–97.

14.

Hamilton R, Andrews I, McKay P, Leach M. Loss of utility of bone marrow biopsy as a staging evaluation for Hodgkin lymphoma in the positron emission tomography-computed tomography era: a West of Scotland study. Leuk Lymphoma. 2013. doi:10.3109/10428194.2013.821201.PubMed

Titel: Primary bone marrow Hodgkin lymphoma in an HIV-negative patient
verfasst von: Bhagirathbhai Dholaria
Daisy Alapat
Konstantinos Arnaoutakis
Publikationsdatum: 01.04.2014
Verlag: Springer Japan
Erschienen in: International Journal of Hematology / Ausgabe 4/2014
Print ISSN: 0925-5710
Elektronische ISSN: 1865-3774
DOI: https://doi.org/10.1007/s12185-014-1532-z

Neu im Fachgebiet Onkologie

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Springer Medizin

Primary bone marrow Hodgkin lymphoma in an HIV-negative patient

Abstract

Neu im Fachgebiet Onkologie

Umsetzung der POMGAT-Leitlinie läuft

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

Sind Frauen die fähigeren Ärzte?

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2014

Progress towards gene therapy for haemophilia B

Clinical features and underlying causes of cerebral venous thrombosis in Japanese patients

Eltrombopag therapy in newly diagnosed steroid non-responsive ITP patients

Cancer gene therapy using mesenchymal stem cells

Narrowband ultraviolet B phototherapy ameliorates acute graft-versus-host disease by a mechanism involving in vivo expansion of CD4+CD25+Foxp3+ regulatory T cells

Successful allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning for B-cell prolymphocytic leukemia in partial remission

Neu im Fachgebiet Onkologie

Umsetzung der POMGAT-Leitlinie läuft

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

Sind Frauen die fähigeren Ärzte?

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Onkologie